Ioannis Mantzaris - Commercial Director - Quartic Training Ltd | LinkedIn
Meet the Hematologic Malignancy Team - Dr. Ioannis Mantzaris, MD
Mantzaris Ioannis - Ιατροτεχνολογικά καρδιολογικά προϊόντα - Mantzaris A.E. | LinkedIn
IOANNIS MANTZARIS, MD, Legal Medicine BRONX, NY - NPI 1871865519
Davendra P. Sohal, MD, MPH, MD,MPH
Bevacizumab Added to the Irinotecan and Capecitabine ...
Dr. Jeffrey I. Zwicker, MD | Boston, MA | Oncologist | US News Doctors
Ioannis MANTZARIS | Fellowship | Albert Einstein College of Medicine, NY | AECOM | Albert Einstein Cancer Center - Page 2
Investigating Poor Cancer Outcomes in Hispanics | Newsroom | Albert Einstein College of Medicine
Meet the Hematologic Malignancy Team
Ioannis MANTZARIS | Fellowship | Albert Einstein College of Medicine, NY | AECOM | Albert Einstein Cancer Center
Ioannis Mantzaris, MD: Bronx, NY
Novel Drug Shows Promise Against Acute Myeloid Leukemia | Albert Einstein College of Medicine
Dr. Ioannis Mantzaris, MD, Hematology & Oncology Specialist - Bronx, NY | Sharecare
Ioannis Mantzaris, MD: Bronx, NY
Harris Tsakiris - Sales Manager - B. I. Mantzaris S.A. | LinkedIn
Ioannis MANTZARIS | Fellowship | Albert Einstein College of Medicine, NY | AECOM | Albert Einstein Cancer Center
Ioannis Mantzaris, MD, Bronx, NY | Internist
Ioannis MANTZARIS | Fellowship | Albert Einstein College of Medicine, NY | AECOM | Albert Einstein Cancer Center
Differentiating Lung Involvement in Adult T-Cell Leukemia Lymphoma (ATLL) Versus HTLV Infection: Results from a Large Single-Center Cohort with Implications for Staging and Response Criteria - ScienceDirect
Ioannis Mantzaris (@YannisMantz) / Twitter
